AMF/G6PI induces differentiation of leukemic cells via an unknown receptor that differs from gp78

References

• Liotta L A, Mandler R, Murano G, Katz D A, Gordon R K, Chiang P K, Schiffmann E. Tumor cell autocrine motility factor. Proc Natl Acad Sci (USA) 1986; 83: 3302–3306
   PubMed Web of Science ®Google Scholar
• Watanabe H, Takehama K, Date M, Shinozaki T, Raz A. Tumor cell motility factor is the neuroleukin/phosphohexose isomerase polypeptide. Cancer Res 1996; 56: 2960–2963
   PubMed Web of Science ®Google Scholar
• Niinaka Y, Paku S, Haga A, Watanabe H, Raz A. Expression and secretion of neuroleukin/phosphohexose isomerase/maturation factor as autocrine motility factor by tumor cells. Cancer Res 1998; 58: 2667–2674
   PubMed Web of Science ®Google Scholar
• Haga A, Niinaka Y, Raz A. Phosphohexose isomerase/autocrine motility factor/neuroleukin/maturation factor is a multifunctional phosphoprotein. Biochim Biophys Acta 2000; 1480: 235–244
   PubMed Web of Science ®Google Scholar
• Gurney M E, Apatoff B R, Spear G T, Baumel M J, Antel J P, Bania M B, Reder A T. Molecular cloning and expression of neuroleukin, a neurotrophic factor for spinal and sensory neurons. Science 1986; 234: 574–581
   PubMed Web of Science ®Google Scholar
• Xu W, Seiter K, Feldman E, Ahmed T, Chiao J W. The differentiation and maturation mediator for human myeloid leukemia cells shares homology with neuroleukin or phosphoglucose isomerase. Blood 1996; 87: 4502–4506
   PubMed Web of Science ®Google Scholar
• Chaput M, Claes V, Portetelle D, Cludts I, Cravador A, Burny A, et al. Related articles, links abstract the neurotrophic factor neuroleukin is 90% homologous with phosphohexose isomerase. Nature 1988; 332: 454–455
   PubMed Web of Science ®Google Scholar
• Shimizu K, Tani M, Watanabe H, Nagamachi Y, Niinaka Y, Shiroishi T, et al. The autocrine motility factor gene encodes a novel type of seven transmembrane protein. FEBS Lett 1999; 456: 295–300
   PubMed Web of Science ®Google Scholar
• Nabi I R, Watanabe H, Raz A. Identification of B16-F1 melanoma autocrine motility-like factor receptor. Cancer Res 1990; 50: 409–414
   PubMed Web of Science ®Google Scholar
• Watanabe H, Nabi I R, Raz A. The relationship between motility factor receptor internalization and the lung colonization capacity of murine melanoma cells. Cancer Res 1991; 51: 2699–2705
   PubMed Web of Science ®Google Scholar
• Funasaka T, Haga A, Raz A, Nagase H. Tumor autocrine motility factor is an angiogenic factor that stimulates endothelial cell motility. Biochem Biophys Res Commun 2001; 284: 1116–1125
   PubMed Web of Science ®Google Scholar
• Funasaka T, Haga A, Raz A, Nagase H. Tumor autocrine motility factor induces hyperpermeability of endothelial and mesothelial cells leading to accumulation of ascites fluid. Biochem Biophys Res Commun 2002; 293: 192–200
   PubMed Web of Science ®Google Scholar
• Funasaka T, Haga A, Raz A, Nagase H. Autocrine motility factor secreted by tumor cells upregulates vascular endothelial growth factor receptor (Flt-1) expression in endothelial cells. Int J Cancer 2002; 101: 217–223
   PubMed Web of Science ®Google Scholar
• Tsutsumi S, Gupta S K, Hogan V, Collard J G, Raz A. Activation of small GTPase rho is required for autocrine motility factor signaling. Cancer Res 2002; 64: 4484–4490
   Google Scholar
• Haga A, Funasaka T, Niinaka Y, Raz A, Nagase H. The autocrine motility factor signaling induces tumor apoptotic resistance which regulates apoptosome expression. Int J Cancer 2003; 105: 707–714
   Web of Science ®Google Scholar
• Luo Y, Long J M, Lu C, Chan S L, Spangler E L, Mascarucci P, et al. A link between maze learning and hippocampal expression of neuroleukin and its receptor gp78. J Neurochemistry 2002; 80: 354–361
   PubMed Web of Science ®Google Scholar
• Saiki I, Iida J, Murata J, Ogawa R, Nishi N, Sugimura K, et al. Inhibition of the metastasis of murine malignant melanoma by synthetic polymeric peptides containing core sequence of cell-adhesive molecule. Cancer Res 1989; 49: 3815–3822
   PubMed Web of Science ®Google Scholar
• Miziachi Y. Neurotrophic activity of monomeric glucophosphoisomerase was blocked by human immunodeficiency virus (HIV-1) and peptides from HIV-1 envelope glycoprotein. J Neurosci Res 1989; 23: 217–224
   PubMed Web of Science ®Google Scholar
• Tsutsumi S, Hogan V, Nabi I R, Raz A. Overexpression of the autocrine motility factor/phosphoglucose isomerase induces transformation and survival of NIH-3T3 fibroblasts. Cancer Res 2003; 63: 242–249
   PubMed Web of Science ®Google Scholar
• Tsutsumi S, Yanagawa T, Shimura T, Fukumori T, Hogan V, Kuwano H, Raz A. Regulation of cell proliferation by autocrine motility factor/phosphoglucose isomerase signaling. J Biol Chem 2003; 278: 32165–32172
   PubMed Web of Science ®Google Scholar
• Niinaka Y, Haga A, Negishi A, Yoshimasu H, Raz A, Amagasa T. Regulation of cell motility via high and low affinity autocrine motility factor (AMF) receptor in human oral squamous carcinoma cells. Oral Oncol 2002; 38: 49–55
   PubMed Web of Science ®Google Scholar
• Tsutsumi S, Gupta S K, Hogan V, Tanaka N, Nakamura K T, Nabi I R, Raz A. The enzymatic activity of phosphoglucose isomerase is not required for its cytokine function. FEBS Lett 2003; 534: 49–53
   PubMed Web of Science ®Google Scholar
• Ip N Y, Nye S H, Boulton T G, Davis S, Taga T, Li Y, et al. CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130. Cell 1992; 69: 1121–1132
   PubMed Web of Science ®Google Scholar
• Bellido T, Stahl N, Farruggella T J, Borba V, Yancopoulos G D, Manolagas S C. Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal/osteoblastic cells. J Clin Invest 1996; 97: 431–437
   PubMed Web of Science ®Google Scholar
• Fang S, Ferrone M, Yang C, Jensen J P, Tiwari S, Weissman A M. The tumor autocrine motility factor receptor, gp78, is a ubiquitin protein ligase implicated in degradation from the endoplasmic reticulum. Proc Natl Acad Sci (USA) 2001; 98: 14422–14427
   PubMed Web of Science ®Google Scholar
• Tobler A, Moser B, Dewald B, Geiser T, Studer H, Baggiolini M, Fey M F. Constitutive expression of interleukin-8 and its receptor in human myeloid and lymphoid leukemia. Blood 1993; 82: 2517–2525
   PubMed Web of Science ®Google Scholar
• van Riper G, Siciliano S, Fischer P A, Meurer R, Springer M S, Rosen H. Characterization and species distribution of high affinity GTP-coupled receptors for human rantes and monocyte chemoattractant protein 1. J Exp Med 1993; 177: 851–856
   PubMed Web of Science ®Google Scholar
• Hiraoka M, Nitta N, Nagai M, Shimokado K, Yoshida M. MCP-1-induced enhancement of THP-1 adhesion to vascular endothelium was modulated by HMG-CoA reductase inhibitor through RhoA GTPase-, but not ERK1/2-dependent pathway. Life Sci 2004; 75: 1333–1341
   PubMed Web of Science ®Google Scholar
• Le P U, Benlimame N, Lagana A, Raz A, Nabi I R. Clathrin-mediated endocytosis and recycling of autocrine motility factor receptor to fibronectin fibrils is a limiting factor for NIH-3T3 cell motility. J Cell Sci 2000; 113: 3227–3240
   PubMed Web of Science ®Google Scholar
• Amraei M, Nabi I R. Species specificity of the cytokine function of phosphoglucose isomerase. FEBS Lett 2002; 525: 151–155
   PubMed Web of Science ®Google Scholar